Your browser doesn't support javascript.
loading
Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease.
Váradi, Zsófia; Bánusz, Rita; Csomor, Judit; Kállay, Krisztián; Varga, Edit; Kertész, Gabriella; Csóka, Monika.
Afiliação
  • Váradi Z; Second Department of Pediatrics.
  • Bánusz R; Second Department of Pediatrics.
  • Csomor J; First Department of Pathology and Experimental Cancer Research, Semmelweis University.
  • Kállay K; Pediatric Hematology and Stem Cell Transplantation Unit, United St István and St László Hospital, Budapest, Hungary.
  • Varga E; Second Department of Pediatrics.
  • Kertész G; Second Department of Pediatrics.
  • Csóka M; Second Department of Pediatrics.
Onco Targets Ther ; 10: 521-526, 2017.
Article em En | MEDLINE | ID: mdl-28182116
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2017 Tipo de documento: Article